Article

Development and psychometric evaluation of the Endometriosis Treatment Satisfaction Questionnaire.

Pfizer, Patient-reported Outcomes, Primary Care, 500 Arcola Rd, Collegeville, PA 19426, USA.
Quality of Life Research (impact factor: 2.3). 04/2010; 19(6):899-905. DOI:10.1007/s11136-010-9640-6 pp.899-905
Source: PubMed

ABSTRACT To develop and psychometrically evaluate the Endometriosis Treatment Satisfaction Questionnaire, a patient-reported assessment of satisfaction with endometriosis treatment.
The Endometriosis Treatment Satisfaction Questionnaire was developed based on the results of five focus groups and three iterative sets of cognitive interviews along with expert opinion and a review of the literature. The psychometric properties were assessed using data collected during a multicenter, randomized, proof-of-concept trial. The development and validation processes followed the guidance recommended by the United States FDA for patient-reported outcome instruments.
The Endometriosis Treatment Satisfaction Questionnaire's reliability, validity, and utility as a measure of patient satisfaction with their endometriosis treatment were supported. The results of the item-level analyses showed no evidence of distributional anomalies or response scale biases. The Endometriosis Treatment Satisfaction Questionnaire is unidimensional, has excellent internal consistency reliability, and discriminates well between known groups. Scores correlated well with other patient-reported outcome measures of endometriosis without being redundant.
The Endometriosis Treatment Satisfaction Questionnaire has utility for assessing patient satisfaction with endometriosis treatment and may be useful in clinical trials that are assessing new treatments for endometriosis, especially when deciding between competing treatments or regimens that are found to have similar tolerability and efficacy.

0 0
 · 
0 Bookmarks
 · 
34 Views
  • Source
    Article: Development of a questionnaire to assess patient satisfaction with allergen-specific immunotherapy in adults: item generation, item reduction, and preliminary validation.
    Jose Luis Justícia, Eva Baró, Victoria Cardona, Pedro Guardia, Pedro Ojeda, José Maria Olaguíbel, José Maria Vega, Carmen Vidal
    [show abstract] [hide abstract]
    ABSTRACT: Allergen-specific immunotherapy (SIT) is a treatment capable of modifying the natural course of allergy, so ensuring good adherence to SIT is fundamental. Up until now there has not existed an instrument specifically developed to measure patient satisfaction with SIT, although its assessment could help us to comprehend better and improve treatment adherence and effectiveness. The aim of this study was to develop an instrument to measure adult patient satisfaction with SIT. Items were generated from a literature review, focus groups with allergic adult patients undergoing SIT, and a meeting with experts. Potential items were administered to allergic patients undergoing SIT in an observational, cross-sectional, multicenter study. Item reduction was based on quantitative and qualitative criteria. A preliminary assessment of feasibility, reliability, and validity of the retained items was performed. An initial pool of 70 items was administered to 257 patients undergoing SIT. Fifty-four items were eliminated resulting in a provisional instrument with 16 items. Factor analysis yielded four factors that were identified as perceived efficacy, activities and environment, cost-benefit balance, and overall satisfaction, explaining 74.8% of variance. Ceiling and floor effects were negligible for overall score. Overall score was associated with the type and intensity of symptoms. This is the first attempt to develop a satisfaction with SIT measure from the perspective of the allergic patient, and evidence has been found in favor of its reliability and validity.
    Patient Preference and Adherence 01/2011; 5:239-50. · 1.14 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

Keywords

clinical trials
 
cognitive interviews
 
endometriosis treatment
 
Endometriosis Treatment Satisfaction Questionnaire
 
Endometriosis Treatment Satisfaction Questionnaire's reliability
 
excellent internal consistency reliability
 
expert opinion
 
focus groups
 
new treatments
 
patient satisfaction
 
patient-reported assessment
 
patient-reported outcome instruments
 
patient-reported outcome measures
 
proof-of-concept trial
 
psychometric properties
 
randomized
 
response scale biases
 
Scores correlated
 
similar tolerability
 
United States FDA
 

Linda S Deal